HR 7693
  • Introduced
    Feb 25, 2026
  • Passed House
  • Passed Senate
  • Became Law
HR 7693
United States House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.
Last Action See all actions
House • Feb 25, 2026: Referred to the House Committee on Energy and Commerce.

Summary

Comments on HR 7693

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Feb 25, 2026 | House
    • Introduced in House
    • Referred to the House Committee on Energy and Commerce.
Bill Texts
Looks like there aren't any bill texts available at this moment.
Documents
Looks like we don't have any documents available at this moment.
Sources